2fww: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2fww.gif|left|200px]] | [[Image:2fww.gif|left|200px]] | ||
<!-- | |||
The line below this paragraph, containing "STRUCTURE_2fww", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_2fww| PDB=2fww | SCENE= }} | |||
}} | |||
'''human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme''' | '''human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme''' | ||
Line 28: | Line 25: | ||
[[Category: Katz, B A.]] | [[Category: Katz, B A.]] | ||
[[Category: 29382]] | [[Category: 29382]] | ||
[[Category: | [[Category: Proteinase]] | ||
[[Category: | [[Category: Serine protease]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 04:24:08 2008'' | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on |
Revision as of 04:24, 4 May 2008
human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme
OverviewOverview
Improved peptide-based inhibitors of human beta tryptase were discovered using information gleaned from tripeptide library screening and structure-guided design methods, including fragment screening. Our efforts sought to improve this class of inhibitors by replacing the traditional Lys or Arg P1 element. The optimized compounds display low nanomolar potency against the mast cell target and several hundred-fold selectivity with respect to serine protease off targets. Thus, replacement of Lys/Arg at P1 in a peptide-like scaffold does not need to be accompanied by a loss in target affinity.
About this StructureAbout this Structure
2FWW is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
Structure-guided design of peptide-based tryptase inhibitors., McGrath ME, Sprengeler PA, Hirschbein B, Somoza JR, Lehoux I, Janc JW, Gjerstad E, Graupe M, Estiarte A, Venkataramani C, Liu Y, Yee R, Ho JD, Green MJ, Lee CS, Liu L, Tai V, Spencer J, Sperandio D, Katz BA, Biochemistry. 2006 May 16;45(19):5964-73. PMID:16681368 Page seeded by OCA on Sun May 4 04:24:08 2008